Exact Mass: 872.7471757999999

TG(15:0/16:0/22:2(13Z,16Z))

C56H104O6 (872.7832484)

TG(15:0/16:0/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:0/22:2(13Z,16Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:0/20:2n6)

C56H104O6 (872.7832484)

TG(15:0/18:0/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:0/20:2n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:0/18:2(9Z,12Z))

C56H104O6 (872.7832484)

TG(15:0/20:0/18:2(9Z,12Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:0/18:2(9Z,12Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/14:1(9Z)/24:1(15Z))

C56H104O6 (872.7832484)

TG(15:0/14:1(9Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/14:1(9Z)/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/16:1(9Z)/22:1(13Z))

C56H104O6 (872.7832484)

TG(15:0/16:1(9Z)/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:1(9Z)/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(11Z)/20:1(11Z))

C56H104O6 (872.7832484)

TG(15:0/18:1(11Z)/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(11Z)/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(9Z)/20:1(11Z))

C56H104O6 (872.7832484)

TG(15:0/18:1(9Z)/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(9Z)/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:1(11Z)/18:1(11Z))

C56H104O6 (872.7832484)

TG(15:0/20:1(11Z)/18:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:1(11Z)/18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:1(11Z)/18:1(9Z))

C56H104O6 (872.7832484)

TG(15:0/20:1(11Z)/18:1(9Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:1(11Z)/18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/22:1(13Z)/16:1(9Z))

C56H104O6 (872.7832484)

TG(15:0/22:1(13Z)/16:1(9Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/22:1(13Z)/16:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/24:1(15Z)/14:1(9Z))

C56H104O6 (872.7832484)

TG(15:0/24:1(15Z)/14:1(9Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/24:1(15Z)/14:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:2(9Z,12Z)/20:0)

C56H104O6 (872.7832484)

TG(15:0/18:2(9Z,12Z)/20:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:2(9Z,12Z)/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of linoleic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:2n6/18:0)

C56H104O6 (872.7832484)

TG(15:0/20:2n6/18:0) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:2n6/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/22:2(13Z,16Z)/16:0)

C56H104O6 (872.7832484)

TG(15:0/22:2(13Z,16Z)/16:0) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/22:2(13Z,16Z)/16:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of docosadienoic acid at the C-2 position and one chain of palmitic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/15:0/22:2(13Z,16Z))

C56H104O6 (872.7832484)

TG(16:0/15:0/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/15:0/22:2(13Z,16Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/15:0/20:2n6)

C56H104O6 (872.7832484)

TG(18:0/15:0/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/15:0/20:2n6), in particular, consists of one chain of stearic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/15:0/18:2(9Z,12Z))

C56H104O6 (872.7832484)

TG(20:0/15:0/18:2(9Z,12Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/15:0/18:2(9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:1(9Z)/15:0/24:1(15Z))

C56H104O6 (872.7832484)

TG(14:1(9Z)/15:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:1(9Z)/15:0/24:1(15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:1(9Z)/15:0/22:1(13Z))

C56H104O6 (872.7832484)

TG(16:1(9Z)/15:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/15:0/22:1(13Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(11Z)/15:0/20:1(11Z))

C56H104O6 (872.7832484)

TG(18:1(11Z)/15:0/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/15:0/20:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(9Z)/15:0/20:1(11Z))

C56H104O6 (872.7832484)

TG(18:1(9Z)/15:0/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/15:0/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(17:0/18:1(9Z)/18:1(9Z))

C56H104O6 (872.7832484)

Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TG(17:0/18:1(9Z)/18:1(9Z)), in particular, consists of one chain of margaric acid at the C-1 position, one chain of oleic acid at the C-2 position, and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, and play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins.

PA(24:0/24:0)

C51H101O8P (872.7233676)

PA(24:0/24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:0/24:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-24:0/i-24:0)

C51H101O8P (872.7233676)

PA(i-24:0/i-24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-24:0/i-24:0), in particular, consists of one chain of isotetracosanoic acid at the C-1 position and one chain of isotetracosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Triacylglycerol 17:0-18:1-18:1

C56H104O6 (872.7832484)

TG(14:0/17:0/22:2(13Z,16Z))[iso6]

C56H104O6 (872.7832484)

TG(14:0/17:1(9Z)/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(14:0/17:2(9Z,12Z)/22:0)[iso6]

C56H104O6 (872.7832484)

TG(14:0/18:2(9Z,12Z)/21:0)[iso6]

C56H104O6 (872.7832484)

TG(14:0/19:0/20:2(11Z,14Z))[iso6]

C56H104O6 (872.7832484)

TG(14:0/19:1(9Z)/20:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(14:1(9Z)/17:0/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(14:1(9Z)/17:1(9Z)/22:0)[iso6]

C56H104O6 (872.7832484)

TG(14:1(9Z)/18:1(9Z)/21:0)[iso6]

C56H104O6 (872.7832484)

TG(14:1(9Z)/19:0/20:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(14:1(9Z)/19:1(9Z)/20:0)[iso6]

C56H104O6 (872.7832484)

TG(15:0/16:0/22:2(13Z,16Z))[iso6]

C56H104O6 (872.7832484)

TG(15:0/16:1(9Z)/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(15:0/17:2(9Z,12Z)/21:0)[iso6]

C56H104O6 (872.7832484)

TG(15:0/18:0/20:2(11Z,14Z))[iso6]

C56H104O6 (872.7832484)

TG(15:0/18:1(9Z)/20:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(15:0/18:2(9Z,12Z)/20:0)[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/16:0/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/16:1(9Z)/22:0)[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/17:1(9Z)/21:0)[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/18:0/20:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/18:1(9Z)/20:0)[iso6]

C56H104O6 (872.7832484)

TG(15:1(9Z)/19:0/19:1(9Z))[iso6]

C56H104O6 (872.7832484)

TG(16:0/18:1(9Z)/19:1(9Z))[iso6]

C56H104O6 (872.7832484)

TG(16:1(9Z)/18:0/19:1(9Z))[iso6]

C56H104O6 (872.7832484)

TG(17:0/17:1(9Z)/19:1(9Z))[iso6]

C56H104O6 (872.7832484)

TG(16:1/17:0/20:1)[iso6]

C56H104O6 (872.7832484)

TG(17:2/18:0/18:0)[iso3]

C56H104O6 (872.7832484)

TG(17:0/18:1/18:1)[iso3]

C56H104O6 (872.7832484)

TG(17:1/18:0/18:1)[iso6]

C56H104O6 (872.7832484)

TG(17:0/18:0/18:2)[iso6]

C56H104O6 (872.7832484)

TG(16:0/17:2/20:0)[iso6]

C56H104O6 (872.7832484)

TG(16:1/17:1/20:0)[iso6]

C56H104O6 (872.7832484)

TG(16:0/17:1/20:1)[iso6]

C56H104O6 (872.7832484)

TG(16:0/17:0/20:2)[iso6]

C56H104O6 (872.7832484)

TG(17:0/17:2/19:0)[iso6]

C56H104O6 (872.7832484)

TG(17:1/17:1/19:0)[iso3]

C56H104O6 (872.7832484)

TG(16:0/18:2/19:0)[iso6]

C56H104O6 (872.7832484)

TG(16:1/18:1/19:0)[iso6]

C56H104O6 (872.7832484)

TG(16:1/16:1/21:0)[iso3]

C56H104O6 (872.7832484)

TG(13:0/20:1(11Z)/20:1(11Z))[iso3]

C56H104O6 (872.7832484)

1-pentadecanoyl-2,3-di9Z-nonadecenoyl-sn-glycerol

C56H104O6 (872.7832484)

TG(12:0/19:0/22:2(13Z,16Z))[iso6]

C56H104O6 (872.7832484)

TG(12:0/19:1(9Z)/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(12:0/20:2(11Z,14Z)/21:0)[iso6]

C56H104O6 (872.7832484)

TG(13:0/18:0/22:2(13Z,16Z))[iso6]

C56H104O6 (872.7832484)

TG(13:0/18:1(9Z)/22:1(11Z))[iso6]

C56H104O6 (872.7832484)

TG(13:0/18:2(9Z,12Z)/22:0)[iso6]

C56H104O6 (872.7832484)

TG(13:0/20:0/20:2(11Z,14Z))[iso6]

C56H104O6 (872.7832484)

TG 53:2

C56H104O6 (872.7832484)

N-(2-hydroxyoctacosanoyl)-15-methylhexadecasphing-4-enine-1-phosphocholine

C50H101N2O7P (872.7346006)

Glycerol 1-heptadecanoate 2,3-dioleate

C56H104O6 (872.7832484)

NAGlySer 22:3/26:0

C53H96N2O7 (872.7217146)

NAGlySer 26:0/22:3

C53H96N2O7 (872.7217146)

NAGlySer 22:2/26:1

C53H96N2O7 (872.7217146)

NAGlySer 26:1/22:2

C53H96N2O7 (872.7217146)

NAGlySer 26:3/22:0

C53H96N2O7 (872.7217146)

NAGlySer 24:1/24:2

C53H96N2O7 (872.7217146)

NAGlySer 24:3/24:0

C53H96N2O7 (872.7217146)

NAGlySer 22:1/26:2

C53H96N2O7 (872.7217146)

NAGlySer 24:2/24:1

C53H96N2O7 (872.7217146)

NAGlySer 26:2/22:1

C53H96N2O7 (872.7217146)

[(E)-2-(heptacosanoylamino)-3,4-dihydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H101N2O7P (872.7346006)

PE-Cer 24:0;2O/25:0

C51H105N2O6P (872.770984)

PE-Cer 23:0;2O/26:0

C51H105N2O6P (872.770984)

PE-Cer 26:0;2O/23:0

C51H105N2O6P (872.770984)

PE-Cer 25:0;2O/24:0

C51H105N2O6P (872.770984)

PE-Cer 22:0;2O/26:1;O

C50H101N2O7P (872.7346006)

PE-Cer 24:0;2O/24:1;O

C50H101N2O7P (872.7346006)

PE-Cer 23:0;2O/25:1;O

C50H101N2O7P (872.7346006)

PE-Cer 24:1;2O/24:0;O

C50H101N2O7P (872.7346006)

PE-Cer 23:1;2O/25:0;O

C50H101N2O7P (872.7346006)

PE-Cer 25:0;2O/23:1;O

C50H101N2O7P (872.7346006)

PE-Cer 25:1;2O/23:0;O

C50H101N2O7P (872.7346006)

PE-Cer 26:1;2O/22:0;O

C50H101N2O7P (872.7346006)

PE-Cer 22:1;2O/26:0;O

C50H101N2O7P (872.7346006)

PE-Cer 26:0;2O/22:1;O

C50H101N2O7P (872.7346006)

[1-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C59H100O4 (872.76212)

[1-hydroxy-3-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoxy]propan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C59H100O4 (872.76212)

[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C59H100O4 (872.76212)

[1-hydroxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C59H100O4 (872.76212)

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C59H100O4 (872.76212)

[3-Hydroxy-2-(nonanoylamino)heptatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C59H100O4 (872.76212)

[2-(Heptatriacontanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(octanoylamino)octatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Decanoylamino)-3-hydroxyhexatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tetradecanoylamino)dotriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(undecanoylamino)pentatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tridecanoylamino)tritriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(pentadecanoylamino)hentriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tetratriacontanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Dodecanoylamino)-3-hydroxytetratriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Hexatriacontanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tritriacontanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(pentatriacontanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-13,16,19,22,25,28,31,34,37-nonaenoate

C58H96O5 (872.7257365999999)

[1-[(Z)-henicos-11-enoyl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoate

C58H96O5 (872.7257365999999)

(1-henicosanoyloxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate

C58H96O5 (872.7257365999999)

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-17,20,23,26,29,32,35-heptaenoate

C58H96O5 (872.7257365999999)

(1-hydroxy-3-tricosanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoate

C58H96O5 (872.7257365999999)

(1-hydroxy-3-undecanoyloxypropan-2-yl) (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenoate

C58H96O5 (872.7257365999999)

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropan-2-yl] (15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-15,18,21,24,27,30,33-heptaenoate

C58H96O5 (872.7257365999999)

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-15,18,21,24,27,30,33,36,39-nonaenoate

C58H96O5 (872.7257365999999)

[1-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoate

C58H96O5 (872.7257365999999)

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoate

C58H96O5 (872.7257365999999)

(1-hydroxy-3-nonadecanoyloxypropan-2-yl) (9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoate

C58H96O5 (872.7257365999999)

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-18,21,24,27,30,33,36,39-octaenoate

C58H96O5 (872.7257365999999)

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-16,19,22,25,28,31,34,37-octaenoate

C58H96O5 (872.7257365999999)

[1-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hydroxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoate

C58H96O5 (872.7257365999999)

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-14,17,20,23,26,29,32,35-octaenoate

C58H96O5 (872.7257365999999)

(2-nonanoyloxy-3-octanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

C56H104O6 (872.7832484)

(3-octanoyloxy-2-pentadecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C56H104O6 (872.7832484)

[3-nonanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] octacosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] heptacosanoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] pentacosanoate

C56H104O6 (872.7832484)

(2-hexadecanoyloxy-3-nonanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C56H104O6 (872.7832484)

[1-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-nonanoyloxypropan-2-yl] docosanoate

C56H104O6 (872.7832484)

[3-nonanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] hexacosanoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] pentacosanoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-nonanoyloxypropyl] (Z)-octacos-17-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] hexacosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] heptacosanoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] tetracosanoate

C56H104O6 (872.7832484)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-octanoyloxypropyl] tricosanoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] tetracosanoate

C56H104O6 (872.7832484)

[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] tricosanoate

C56H104O6 (872.7832484)

(2-heptadecanoyloxy-3-octanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C56H104O6 (872.7832484)

(3-octanoyloxy-2-tridecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C56H104O6 (872.7832484)

(3-nonanoyloxy-2-octadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

(2-icosanoyloxy-3-nonanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

(2-dodecanoyloxy-3-nonanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C56H104O6 (872.7832484)

(2-decanoyloxy-3-nonanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C56H104O6 (872.7832484)

(2-henicosanoyloxy-3-octanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

(3-nonanoyloxy-2-tetradecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C56H104O6 (872.7832484)

[2-[(Z)-docos-13-enoyl]oxy-3-nonanoyloxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-henicos-11-enoyl]oxy-3-octanoyloxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

(3-octanoyloxy-2-undecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C56H104O6 (872.7832484)

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] nonacosanoate

C56H104O6 (872.7832484)

[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C56H104O6 (872.7832484)

(2-nonadecanoyloxy-3-octanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] octacosanoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-octacos-17-enoate

C56H104O6 (872.7832484)

[2-[(Z)-icos-11-enoyl]oxy-3-nonanoyloxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

(2-octadecanoyloxy-3-tridecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-pentadecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[2-octadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] pentacosanoate

C56H104O6 (872.7832484)

[2-pentadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-nonadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] icosanoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-undecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-henicosanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-undecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

(3-dodecanoyloxy-2-icosanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

C56H104O6 (872.7832484)

(2-octadecanoyloxy-3-tetradecanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tricosanoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] tetracosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] tricosanoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] henicosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

(2-tetradecanoyloxy-3-tridecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[1-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-undecanoyloxypropan-2-yl] henicosanoate

C56H104O6 (872.7832484)

(3-dodecanoyloxy-2-heptadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] hexacosanoate

C56H104O6 (872.7832484)

[2-hexadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] hexacosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] tricosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-heptadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

2,3-bis[[(Z)-tridec-9-enoyl]oxy]propyl heptacosanoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-heptadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

(2-nonadecanoyloxy-3-tridecanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

C56H104O6 (872.7832484)

[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] tricosanoate

C56H104O6 (872.7832484)

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] pentacosanoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tetracosanoate

C56H104O6 (872.7832484)

2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propyl pentacosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(Z)-henicos-11-enoyl]oxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C56H104O6 (872.7832484)

(2-icosanoyloxy-3-undecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] henicosanoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tricosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] heptacosanoate

C56H104O6 (872.7832484)

(3-decanoyloxy-2-tridecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C56H104O6 (872.7832484)

[2-tetradecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

(2-pentadecanoyloxy-3-tetradecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-icos-11-enoyl]oxy-3-undecanoyloxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-tetradec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-octacos-17-enoate

C56H104O6 (872.7832484)

(3-dodecanoyloxy-2-pentadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

(2-tetradecanoyloxy-3-undecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

(2-octadecanoyloxy-3-undecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-tetradec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] tricosanoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-tetracos-13-enoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

(2-hexadecanoyloxy-3-tridecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C56H104O6 (872.7832484)

[1-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] icosanoate

C56H104O6 (872.7832484)

[2-nonadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] tetracosanoate

C56H104O6 (872.7832484)

(3-dodecanoyloxy-2-tridecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] tetracosanoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] tetracosanoate

C56H104O6 (872.7832484)

(2-dodecanoyloxy-3-undecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] tricosanoate

C56H104O6 (872.7832484)

(2-heptadecanoyloxy-3-tetradecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] tetracosanoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

(3-dodecanoyloxy-2-nonadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

[3-decanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] hexacosanoate

C56H104O6 (872.7832484)

(2-hexadecanoyloxy-3-undecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C56H104O6 (872.7832484)

[3-[(Z)-hexadec-9-enoyl]oxy-2-octadecanoyloxypropyl] (Z)-nonadec-9-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[2-heptadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

2,3-di(heptadecanoyloxy)propyl (9Z,12Z)-nonadeca-9,12-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

2,3-bis[[(Z)-hexadec-9-enoyl]oxy]propyl henicosanoate

C56H104O6 (872.7832484)

[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-nonadec-9-enoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] henicosanoate

C56H104O6 (872.7832484)

(2-hexadecanoyloxy-3-pentadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-heptadecanoyloxypropyl] nonadecanoate

C56H104O6 (872.7832484)

[1-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropan-2-yl] nonadecanoate

C56H104O6 (872.7832484)

2,3-bis[[(Z)-pentadec-9-enoyl]oxy]propyl tricosanoate

C56H104O6 (872.7832484)

[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-nonadec-9-enoate

C56H104O6 (872.7832484)

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

[2-[(Z)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[1-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] octadecanoate

C56H104O6 (872.7832484)

[2-hexadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

[3-hexadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

C56H104O6 (872.7832484)

(2-heptadecanoyloxy-3-pentadecanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

C56H104O6 (872.7832484)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] octadecanoate

C56H104O6 (872.7832484)

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] nonadecanoate

C56H104O6 (872.7832484)

[3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

C56H104O6 (872.7832484)

[2-heptadecanoyloxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

2,3-di(hexadecanoyloxy)propyl (11Z,14Z)-henicosa-11,14-dienoate

C56H104O6 (872.7832484)

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] nonadecanoate

C56H104O6 (872.7832484)

[1-heptadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropan-2-yl] octadecanoate

C56H104O6 (872.7832484)

(3-hexadecanoyloxy-2-octadecanoyloxypropyl) (9Z,12Z)-nonadeca-9,12-dienoate

C56H104O6 (872.7832484)

2,3-bis[[(Z)-heptadec-9-enoyl]oxy]propyl nonadecanoate

C56H104O6 (872.7832484)

PEtOH 22:0_24:0

C51H101O8P (872.7233676)

PEtOH 23:0_23:0

C51H101O8P (872.7233676)

PEtOH 21:0_25:0

C51H101O8P (872.7233676)

PMeOH 21:0_26:0

C51H101O8P (872.7233676)

PMeOH 22:0_25:0

C51H101O8P (872.7233676)

PMeOH 20:0_27:0

C51H101O8P (872.7233676)

PMeOH 23:0_24:0

C51H101O8P (872.7233676)

PEtOH 19:0_27:0

C51H101O8P (872.7233676)

PEtOH 20:0_26:0

C51H101O8P (872.7233676)

[3-Hydroxy-2-(octatriacontanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Hexacosanoylamino)-3-hydroxyicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(pentacosanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tetracosanoylamino)docosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(triacontanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Hentriacontanoylamino)-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Docosanoylamino)-3-hydroxytetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Henicosanoylamino)-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Dotriacontanoylamino)-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Heptadecanoylamino)-3-hydroxynonacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(tricosanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Heptacosanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[2-(Hexadecanoylamino)-3-hydroxytriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(icosanoylamino)hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(octacosanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(nonacosanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(octadecanoylamino)octacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

[3-Hydroxy-2-(nonadecanoylamino)heptacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H105N2O6P (872.770984)

(1-Docosanoyloxy-3-phosphonooxypropan-2-yl) hexacosanoate

C51H101O8P (872.7233676)

(1-Phosphonooxy-3-tricosanoyloxypropan-2-yl) pentacosanoate

C51H101O8P (872.7233676)

(3-Phosphonooxy-2-tetracosanoyloxypropyl) tetracosanoate

C51H101O8P (872.7233676)

(1-Henicosanoyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

C51H101O8P (872.7233676)

(2-octadecanoyloxy-3-pentadecanoyloxypropyl) (11Z,14Z)-icosa-11,14-dienoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] henicosanoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-nonadec-9-enoate

C56H104O6 (872.7832484)

(2-heptadecanoyloxy-3-hexadecanoyloxypropyl) (11Z,14Z)-icosa-11,14-dienoate

C56H104O6 (872.7832484)

(2-nonadecanoyloxy-3-tetradecanoyloxypropyl) (11Z,14Z)-icosa-11,14-dienoate

C56H104O6 (872.7832484)

[1-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] nonadecanoate

C56H104O6 (872.7832484)

[2-octadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[2-[(Z)-icos-11-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] icosanoate

C56H104O6 (872.7832484)

[1-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecanoyloxypropan-2-yl] icosanoate

C56H104O6 (872.7832484)

[2-nonadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[2-[(Z)-nonadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-icos-11-enoate

C56H104O6 (872.7832484)

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-icosanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

[2-[(4Z,7Z)-hexadeca-4,7-dienoyl]oxy-3-pentadecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

(2-octadecanoyloxy-3-tetradecanoyloxypropyl) (9Z,11Z)-henicosa-9,11-dienoate

C56H104O6 (872.7832484)

[2-octadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-docos-11-enoate

C56H104O6 (872.7832484)

[2-nonadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-henicos-9-enoate

C56H104O6 (872.7832484)

[2-octadecanoyloxy-3-[(9Z,12Z)-pentadeca-9,12-dienoyl]oxypropyl] icosanoate

C56H104O6 (872.7832484)

[2-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxy-3-tridecanoyloxypropyl] henicosanoate

C56H104O6 (872.7832484)

[3-dodecanoyloxy-2-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxypropyl] docosanoate

C56H104O6 (872.7832484)

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-nonadecanoyloxypropyl] docosanoate

C56H104O6 (872.7832484)

[1-[(Z)-heptadec-7-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropan-2-yl] octadecanoate

C56H104O6 (872.7832484)

[2-[(11Z,14Z)-heptadeca-11,14-dienoyl]oxy-3-heptadecanoyloxypropyl] nonadecanoate

C56H104O6 (872.7832484)

N-(tetracosanoyl)-docosasphinganine-1-phosphocholine

C51H105N2O6P (872.770984)

N-(pentacosanoyl)-heneicosasphinganine-1-phosphocholine

C51H105N2O6P (872.770984)

N-(hexacosanoyl)-eicosasphinganine-1-phosphocholine

C51H105N2O6P (872.770984)

[(2R)-1-docosanoyloxy-3-phosphonooxypropan-2-yl] hexacosanoate

C51H101O8P (872.7233676)

[1-carboxy-3-[3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-2-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-docosanoyloxy-2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[(2R)-1-phosphonooxy-3-tricosanoyloxypropan-2-yl] pentacosanoate

C51H101O8P (872.7233676)

[1-carboxy-3-[2-icosanoyloxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-docosanoyloxy-3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(E)-docos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-octadecanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(E)-icos-11-enoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(E)-nonadec-9-enoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(E)-henicos-9-enoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-nonadecanoyloxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-henicosanoyloxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(E)-hexacos-11-enoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[(2R)-2-docosanoyloxy-3-phosphonooxypropyl] hexacosanoate

C51H101O8P (872.7233676)

[(2R)-3-phosphonooxy-2-tricosanoyloxypropyl] pentacosanoate

C51H101O8P (872.7233676)

[1-carboxy-3-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(E)-hexacos-11-enoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-tricosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-tricosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-octadecanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-henicosanoyloxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(E)-nonadec-9-enoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[hydroxy-[(2R)-3-[(E)-icos-1-enoxy]-2-tricosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

[1-carboxy-3-[3-icosanoyloxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[hydroxy-[(2R)-3-[(E)-octadec-1-enoxy]-2-pentacosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

[1-carboxy-3-[2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(E)-icos-11-enoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(E)-henicos-9-enoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-nonadecanoyloxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[3-[2,3-bis[[(14E,16E)-docosa-14,16-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(E)-docos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-hexacosanoyloxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-docosanoyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[[2-heptacosanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

[1-carboxy-3-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-octadecanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-pentacosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

[1-carboxy-3-[3-[(Z)-hexacos-15-enoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-docos-13-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-icosanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[1-carboxy-3-[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

[3-[2,3-bis[[(13Z,16Z)-docosa-13,16-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[hydroxy-[2-[(Z)-octacos-17-enoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[carboxy-[2-hydroxy-3-[(29Z,32Z,35Z,38Z,41Z)-tetratetraconta-29,32,35,38,41-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C54H98NO7+ (872.7342897999999)

2-[hydroxy-[3-octacosoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[3-[(Z)-octacos-17-enoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[3-docosoxy-2-[(Z)-henicos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[3-nonadecoxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[3-[(Z)-docos-13-enoxy]-2-henicosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[3-[(Z)-heptadec-9-enoxy]-2-hexacosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[2-octacosanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[2-nonadecanoyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-tetracosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[2-[(Z)-docos-13-enoyl]oxy-3-henicosoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[2-docosanoyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-pentacosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[2-heptadecanoyloxy-3-[(Z)-hexacos-15-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[3-heptadecoxy-2-[(Z)-hexacos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-tricosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[3-heptacosoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-tricosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-hexacosoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

2-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H103NO7P+ (872.7471757999999)

1-2-Di-tetracosanoyl-sn-glycero-3-phosphate

C51H101O8P (872.7233676)

[(2R)-2,3-bis[(22-methyltricosanoyl)oxy]propoxy]phosphonic acid

C51H101O8P (872.7233676)

BisMePA(46:0)

C51H101O8P (872.7233676)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 59:8;O

C59H100O4 (872.76212)

MGDG O-42:0;O

C51H100O10 (872.73161)

TG O-55:9

C58H96O5 (872.7257365999999)

PA O-14:0/35:0

C52H105O7P (872.759751)

PA O-16:0/33:0

C52H105O7P (872.759751)

PA O-18:0/31:0

C52H105O7P (872.759751)

PA O-20:0/29:0

C52H105O7P (872.759751)

PA O-22:0/27:0

C52H105O7P (872.759751)

PA O-49:0

C52H105O7P (872.759751)

PA 10:0_38:0

C51H101O8P (872.7233676)

PA 11:0_37:0

C51H101O8P (872.7233676)

PA 12:0_36:0

C51H101O8P (872.7233676)

PA 13:0_35:0

C51H101O8P (872.7233676)

PA 14:0_34:0

C51H101O8P (872.7233676)

PA 15:0_33:0

C51H101O8P (872.7233676)

PA 16:0_32:0

C51H101O8P (872.7233676)

PA 17:0_31:0

C51H101O8P (872.7233676)

PA 18:0_30:0

C51H101O8P (872.7233676)

PA 19:0_29:0

C51H101O8P (872.7233676)

PA 20:0_28:0

C51H101O8P (872.7233676)

PA 21:0_27:0

C51H101O8P (872.7233676)

PA 22:0_26:0

C51H101O8P (872.7233676)

PA 23:0_25:0

C51H101O8P (872.7233676)

PA 24:0/24:0

C51H101O8P (872.7233676)

PA 48:0

C51H101O8P (872.7233676)

PEth 46:0

C51H101O8P (872.7233676)

PM 47:0

C51H101O8P (872.7233676)

CerPE 14:0;O2/35:0

C51H105N2O6P (872.770984)

CerPE 15:0;O2/34:0

C51H105N2O6P (872.770984)

CerPE 16:0;O2/33:0

C51H105N2O6P (872.770984)

CerPE 17:0;O2/32:0

C51H105N2O6P (872.770984)

CerPE 18:0;O2/31:0

C51H105N2O6P (872.770984)

CerPE 19:0;O2/30:0

C51H105N2O6P (872.770984)

CerPE 20:0;O2/29:0

C51H105N2O6P (872.770984)

CerPE 21:0;O2/28:0

C51H105N2O6P (872.770984)

CerPE 22:0;O2/27:0

C51H105N2O6P (872.770984)

CerPE 22:1;O2/26:0;O

C50H101N2O7P (872.7346006)

CerPE 23:0;O2/26:0

C51H105N2O6P (872.770984)

CerPE 48:1;O2;O

C50H101N2O7P (872.7346006)

CerPE 49:0;O2

C51H105N2O6P (872.770984)

SM 14:0;O2/32:0

C51H105N2O6P (872.770984)

SM 15:0;O2/31:0

C51H105N2O6P (872.770984)

SM 16:0;O2/30:0

C51H105N2O6P (872.770984)

SM 17:0;O2/29:0

C51H105N2O6P (872.770984)

SM 18:0;O2/28:0

C51H105N2O6P (872.770984)

SM 19:0;O2/27:0

C51H105N2O6P (872.770984)

SM 19:1;O2/26:0;O

C50H101N2O7P (872.7346006)

SM 20:0;O2/26:0

C51H105N2O6P (872.770984)

SM 20:1;O2/25:0;O

C50H101N2O7P (872.7346006)

SM 21:0;O2/24:1;O

C50H101N2O7P (872.7346006)

SM 21:0;O2/25:0

C51H105N2O6P (872.770984)

SM 21:1;O2/24:0;O

C50H101N2O7P (872.7346006)

SM 22:0;O2/24:0

C51H105N2O6P (872.770984)

SM 22:1;O2/23:0;O

C50H101N2O7P (872.7346006)